TY - JOUR
T1 - SOX6 suppresses cyclin D1 promoter activity by interacting with β-catenin and histone deacetylase 1, and its down-regulation induces pancreatic β-cell proliferation
AU - Iguchi, Haruhisa
AU - Urashima, Yasuyo
AU - Inagaki, Yosuke
AU - Ikeda, Yukio
AU - Okamura, Masashi
AU - Tanaka, Toshiya
AU - Uchida, Aoi
AU - Yamamoto, Tokuo T.
AU - Kodama, Tatsuhiko
AU - Sakai, Juro
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/6/29
Y1 - 2007/6/29
N2 - Sex-determining region Y-box (SOX) 6 negatively regulates glucose-stimulated insulin secretion from β-cells and is a down-regulated transcription factor in the pancreatic islet cells of hyperinsulinemic obese mice. To determine the contribution of SOX6 to insulin resistance, we analyzed the effects of SOX6 on cell proliferation. Small interfering RNA-mediated attenuation of SOX6 expression stimulated the proliferation of insulinoma INS-1E and NIH-3T3 cells, whereas retroviral overexpression resulted in inhibition of cell growth. Quantitative real time-PCR analysis revealed that the levels of cyclin D1 transcripts were markedly decreased by SOX6 overexpression. Luciferase-reporter assay with β-catenin showed that SOX6 suppresses cyclin D1 promoter activities. In vitro binding experiments showed that the LZ/Q domain of SOX6 physically interacts with armadillo repeats 1-4 of β-catenin. Furthermore, chromatin immunoprecipitation assay revealed that increased SOX6 expression significantly reduced the levels of acetylated histones H3 and H4 at the cyclin D1 promoter. By using a histone deacetylase (HDAC) inhibitor and co-immunoprecipitation analysis, we showed that SOX6 suppressed cyclin D1 activities by interacting with β-catenin and HDAC1. The data presented suggest that SOX6 may be an important factor in obesity-related insulin resistance.
AB - Sex-determining region Y-box (SOX) 6 negatively regulates glucose-stimulated insulin secretion from β-cells and is a down-regulated transcription factor in the pancreatic islet cells of hyperinsulinemic obese mice. To determine the contribution of SOX6 to insulin resistance, we analyzed the effects of SOX6 on cell proliferation. Small interfering RNA-mediated attenuation of SOX6 expression stimulated the proliferation of insulinoma INS-1E and NIH-3T3 cells, whereas retroviral overexpression resulted in inhibition of cell growth. Quantitative real time-PCR analysis revealed that the levels of cyclin D1 transcripts were markedly decreased by SOX6 overexpression. Luciferase-reporter assay with β-catenin showed that SOX6 suppresses cyclin D1 promoter activities. In vitro binding experiments showed that the LZ/Q domain of SOX6 physically interacts with armadillo repeats 1-4 of β-catenin. Furthermore, chromatin immunoprecipitation assay revealed that increased SOX6 expression significantly reduced the levels of acetylated histones H3 and H4 at the cyclin D1 promoter. By using a histone deacetylase (HDAC) inhibitor and co-immunoprecipitation analysis, we showed that SOX6 suppressed cyclin D1 activities by interacting with β-catenin and HDAC1. The data presented suggest that SOX6 may be an important factor in obesity-related insulin resistance.
UR - http://www.scopus.com/inward/record.url?scp=34547129844&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547129844&partnerID=8YFLogxK
U2 - 10.1074/jbc.M700460200
DO - 10.1074/jbc.M700460200
M3 - Article
C2 - 17412698
AN - SCOPUS:34547129844
SN - 0021-9258
VL - 282
SP - 19052
EP - 19061
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 26
ER -